FDA has approved Cosela (trilaciclib) as the first therapy in its class to reduce the frequency of chemotherapy-induced bone marrow suppression in adults receiving certain types of chemotherapy for extensive-stage small cell lung cancer.
Exact Sciences Corp. has entered into an agreement to acquire Ashion Analytics from The Translational Genomics Research Institute, an affiliate of City of Hope.
The National Comprehensive Cancer Network published its first-ever treatment guidelines for children with a solid tumor cancer type in the United States.
In a SWOG Cancer Research Network trial that put three targeted drugs to the test, the small molecule inhibitor cabozantinib was found most effective in treating patients with metastatic papillary kidney cancer.
A test that monitors blood levels of DNA fragments released by dying tumor cells may serve as an accurate early indicator of treatment success in late stages of melanoma.
Researchers examined body mass index data for people with HER2-positive early breast cancer and found a 5% weight loss in patients over two years was associated with worse outcomes.
Black women experience longer breast cancer treatment times and may have less access to essential radiation technology, according to a study published in Cancer.
A study by researchers at Yale Cancer Center demonstrated that enfortumab vedotin significantly prolonged survival as compared with standard chemotherapy in patients with locally advanced or metastatic urothelial carcinoma or bladder cancer, who had previously received platinum-based treatment and a PD-1–PD-L1 inhibitor.
The Richard Nixon Foundation will host a two-day commemoration of the 1971 National Cancer Act at the Richard Nixon Presidential Library and Museum in Yorba Linda, California, on Dec. 1-2, 2021.
Jeremy Kortmansky was named associate chief medical officer for Network Medical Services and chief network officer at Smilow Cancer Hospital.
